RIA Advisory Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $264K | Buy |
3,831
+776
| +25% | +$53.6K | 0.08% | 104 |
|
|
2025
Q1 | $212K | Buy |
+3,055
| New | +$212K | 0.07% | 131 |
|
|
2024
Q4 | – | Sell |
-2,360
| Closed | -$281K | – | 146 |
|
|
2024
Q3 | $281K | Buy |
+2,360
| New | +$281K | 0.1% | 104 |
|
|
2024
Q1 | $327K | Buy |
+2,545
| New | +$327K | 0.13% | 90 |
|
|
2023
Q4 | – | Sell |
-2,973
| Closed | -$270K | – | 165 |
|
|
2023
Q3 | $270K | Buy |
2,973
+25
| +0.8% | +$2.27K | 0.12% | 88 |
|
|
2023
Q2 | $239K | Buy |
2,948
+320
| +12% | +$25.9K | 0.1% | 102 |
|
|
2023
Q1 | $209K | Buy |
+2,628
| New | +$209K | 0.1% | 108 |
|